222 related articles for article (PubMed ID: 29624682)
21. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010.
Yu D; Ling LE; Krumme AA; Tjoa ML; Moise KJ
AJOG Glob Rep; 2023 May; 3(2):100203. PubMed ID: 37229151
[TBL] [Abstract][Full Text] [Related]
22. Absence of D- alloimmunization in AIDS patients receiving D-mismatched RBCs.
Boctor FN; Ali NM; Mohandas K; Uehlinger J
Transfusion; 2003 Feb; 43(2):173-6. PubMed ID: 12559012
[TBL] [Abstract][Full Text] [Related]
23. Utilization of Rh prophylaxis.
Berger GS; Keith L
Clin Obstet Gynecol; 1982 Jun; 25(2):267-75. PubMed ID: 6179676
[TBL] [Abstract][Full Text] [Related]
24. The frequency of anti-C + anti-G in the absence of anti-D in alloimmunized pregnancies.
Palfi M; Gunnarsson C
Transfus Med; 2001 Jun; 11(3):207-10. PubMed ID: 11422951
[TBL] [Abstract][Full Text] [Related]
25. Red blood cell alloimmunization in pregnancy during the years 1996-2015 in Iceland: a nation-wide population study.
Bollason G; Hjartardottir H; Jonsson T; Gudmundsson S; Kjartansson S; Halldorsdottir AM
Transfusion; 2017 Nov; 57(11):2578-2585. PubMed ID: 28840609
[TBL] [Abstract][Full Text] [Related]
26. Oral administration of Chinese herbal medicine during gestation period for preventing hemolytic disease of the newborn due to ABO incompatibility: A systematic review of randomized controlled trials.
Cao H; Wu R; Han M; Caldwell PHY; Liu JP
PLoS One; 2017; 12(7):e0180746. PubMed ID: 28719639
[TBL] [Abstract][Full Text] [Related]
27. [Management of feto-maternal red cell allo-immunizations].
Bricca P; Guinchard E; Guitton Bliem C
Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of rhesus D-negative blood type and the challenges of rhesus D immunoprophylaxis among obstetric population in Ethiopia: a systematic review and meta-analysis.
Ayenew AA
Matern Health Neonatol Perinatol; 2021 Feb; 7(1):8. PubMed ID: 33531050
[TBL] [Abstract][Full Text] [Related]
29. Hemolytic disease of the fetus and newborn in the sensitizing pregnancy where anti-D was incorrectly identified as RhIG.
Walhof ML; Leon J; Greiner AL; Scott JR; Knudson CM
J Clin Lab Anal; 2022 Apr; 36(4):e24323. PubMed ID: 35243688
[TBL] [Abstract][Full Text] [Related]
30. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
[TBL] [Abstract][Full Text] [Related]
31. Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy.
Okwundu CI; Afolabi BB
Cochrane Database Syst Rev; 2013 Jan; (1):CD007885. PubMed ID: 23440818
[TBL] [Abstract][Full Text] [Related]
32. Rhesus and other blood group incompatibilities in pregnancy.
Gunston KD; Botha I
S Afr Med J; 1980 Oct; 58(16):639-41. PubMed ID: 6775377
[TBL] [Abstract][Full Text] [Related]
33. [Spontaneous antepartal RhD alloimmunization].
Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
[TBL] [Abstract][Full Text] [Related]
34. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
35. Does Rh immune globulin suppress HLA sensitization in pregnancy?
Kaufman RM; Schlumpf KS; Wright DJ; Triulzi DJ;
Transfusion; 2013 Sep; 53(9):2069-77. PubMed ID: 23252646
[TBL] [Abstract][Full Text] [Related]
36. Rh immune globulin immunoprophylaxis after RhD-positive red cell exposure in RhD-negative patients via transfusion: A survey of practices.
Lu W; Stephens L; Shmookler A; O'Brien K; Karp JK; Hermelin D; Bakhtary S; Almozain N; George M; Fung M
Transfusion; 2024 May; 64(5):839-845. PubMed ID: 38534065
[TBL] [Abstract][Full Text] [Related]
37. Occurrence of ABO And RhD Incompatibility with Rh Negative Mothers.
Izetbegovic S
Mater Sociomed; 2013 Dec; 25(4):255-8. PubMed ID: 24511269
[TBL] [Abstract][Full Text] [Related]
38. Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations.
Hendrickson JE; Delaney M
Transfus Med Rev; 2016 Oct; 30(4):159-64. PubMed ID: 27397673
[TBL] [Abstract][Full Text] [Related]
39. [The importance of immunohematology testing in the neonatal period].
Bujandrić N; Milanović MK
Med Pregl; 2013; 66(7-8):317-21. PubMed ID: 24069814
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis of Rh immunization in primigravidas. Fetomaternal versus maternofetal bleeding.
Scott JR; Beer AE; Guy LR; Liesch M; Elbert G
Obstet Gynecol; 1977 Jan; 49(1):9-14. PubMed ID: 401536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
